{"id":1537,"date":"2020-09-01T11:27:45","date_gmt":"2020-09-01T11:27:45","guid":{"rendered":"https:\/\/www.ipsen.com\/spain\/?p=1537"},"modified":"2024-12-16T13:25:32","modified_gmt":"2024-12-16T11:25:32","slug":"juan-lobera-nuevo-director-medico-y-de-asuntos-regulatorios-de-ipsen-para-espana-y-portugal","status":"publish","type":"press_release","link":"https:\/\/www.ipsen.com\/spain\/press-releases\/juan-lobera-nuevo-director-medico-y-de-asuntos-regulatorios-de-ipsen-para-espana-y-portugal\/","title":{"rendered":"Juan Lobera, nuevo director m\u00e9dico y de asuntos regulatorios de Ipsen para Espa\u00f1a y Portugal"},"content":{"rendered":"\n<p><strong>Barcelona, 1 de septiembre de 2020<\/strong>.- Ipsen, compa\u00f1\u00eda biofarmac\u00e9utica global centrada en innovaci\u00f3n y atenci\u00f3n especializada, ha nombrado a Juan Lobera nuevo director m\u00e9dico y de asuntos regulatorios de Ipsen para Espa\u00f1a y Portugal.<\/p>\n\n\n\n<p>Juan Lobera cuenta con una dilatada experiencia en la industria farmac\u00e9utica donde ha desempe\u00f1ado diferentes cargos de responsabilidad durante los \u00faltimos 15 a\u00f1os. Desde su nuevo puesto en Ipsen reportar\u00e1 directamente a Aurora Berra, directora general de la compa\u00f1\u00eda para Espa\u00f1a y Portugal, y formar\u00e1 parte del comit\u00e9 de direcci\u00f3n.<\/p>\n\n\n\n<p>\u201cAsumir la direcci\u00f3n m\u00e9dica y de asuntos regulatorios de Ipsen para Espa\u00f1a y Portugal es una gran oportunidad, un enorme orgullo y un reto que afronto con mucha ilusi\u00f3n. Seguir\u00e9 comprometido en consolidar este departamento y en alcanzar el \u00e9xito a trav\u00e9s de la innovaci\u00f3n y la diferenciaci\u00f3n que aporten valor a nuestro sector. Soy muy afortunado de contar con un equipo de excelentes profesionales, altamente comprometidos que, estoy seguro, ser\u00e1n la clave para seguir avanzando en nuestro principal objetivo, mejorar la calidad de vida de los pacientes\u201d, ha explicado Juan Lobera.<\/p>\n\n\n\n<p>Juan es Licenciado en Medicina, por la Universidad de Navarra, especialista en Microbiolog\u00eda y Parasitolog\u00eda Cl\u00ednica. Inici\u00f3 su carrera en la industria farmac\u00e9utica en Schering AG Spain. Posteriormente trabaj\u00f3 en Roche Farma Spain, HRA Pharma Espa\u00f1a, LifeScan (Johnson &amp; Johnson company), Biogen Spain y AstraZeneca Spain, desde donde se incorpora a Ipsen.<\/p>\n\n\n\n<p><strong>Sobre Ipsen<\/strong><\/p>\n\n\n\n<p>Ipsen es una compa\u00f1\u00eda biofarmac\u00e9utica global centrada en la innovaci\u00f3n y atenci\u00f3n especializada. La compa\u00f1\u00eda desarrolla y comercializa medicamentos innovadores en 3 \u00e1reas terap\u00e9uticas clave: oncolog\u00eda, neurociencias y enfermedades raras. Su compromiso con la oncolog\u00eda se traduce en una cartera creciente de terapias clave para c\u00e1ncer de pr\u00f3stata, tumores neuroendocrinos, carcinomas de c\u00e9lulas renales, hepatocarcinoma y c\u00e1ncer de p\u00e1ncreas. Ipsen tambi\u00e9n est\u00e1 presente en atenci\u00f3n primaria y autocuidado de la salud. Con un volumen de negocio de 2.500 millones de euros en 2019, Ipsen comercializa m\u00e1s de 20 medicamentos en m\u00e1s de 115 pa\u00edses, y cuenta con presencia comercial directa en m\u00e1s de 30 pa\u00edses. La I+D de Ipsen se centra en sus plataformas tecnol\u00f3gicas diferenciadas e innovadoras, ubicadas en los principales centros biotecnol\u00f3gicos y ciudades de referencia en ciencias de la vida: Par\u00eds-Saclay (Francia), Oxford (Reino Unido) y Cambridge (Estados Unidos). El grupo cuenta con unos 5.800 empleados en todo el mundo. Ipsen cotiza en la bolsa de Par\u00eds (Euronext: IPN), y, en 2 \/ 2 Estados Unidos, participa en el American Depositary Receipt program patrocinado de nivel 1.<\/p>\n\n\n\n<p>Ipsen Pharma Espa\u00f1a se encuentra ubicada en Hospitalet de Llobregat (Barcelona). En Espa\u00f1a, la compa\u00f1\u00eda dispone de un s\u00f3lido porfolio en oncolog\u00eda (ri\u00f1\u00f3n, pr\u00f3stata, h\u00edgado, tiroides y tumores neuroendocrinos), enfermedades raras (acromegalia, adenoma tirotropo, fibrodisplasia osificante progresiva (FOP), S\u00edndrome de Turner y trastornos del crecimiento) y neurociencias (trastornos del movimiento). Para m\u00e1s informaci\u00f3n, visita los sitios web: <a href=\"http:\/\/www.ipsen.com\" target=\"_blank\" rel=\"noreferrer noopener\"><strong>www.ipsen.com<\/strong><\/a> y <a href=\"http:\/\/www.ipsen.com\/spain\/\"><strong>www.ipsen.com\/spain<\/strong><\/a><\/p>\n\n\n\n<h4 class=\"wp-block-heading\"><br><strong>Para m\u00e1s informaci\u00f3n:<\/strong><\/h4>\n\n\n\n<figure class=\"wp-block-table\"><table class=\"has-fixed-layout\"><tbody><tr><td><strong>Ipsen<\/strong><br><br><strong>Loreto Gonz\u00e1lez Goizueta<\/strong><br>Tel\u00e9fono: 93 685 81 00<br>Email:<a href=\"mailto:loreto.gonzalez@ipsen.com\" target=\"_blank\" rel=\"noreferrer noopener\">&nbsp;loreto.gonzalez@ipsen.com<\/a><\/td><td><strong>Duomo Comunicaci\u00f3n<\/strong><br><br><strong>Borja G\u00f3mez<\/strong><br>Tel\u00e9fono: 91 311 92 89 \/650 40 22 25<br><a href=\"mailto:borja_gomez@duomocomunicacion.com\" target=\"_blank\" rel=\"noreferrer noopener\">borja_gomez@duomocomunicacion.com<\/a><\/td><\/tr><\/tbody><\/table><\/figure>\n","protected":false},"excerpt":{"rendered":"","protected":false},"author":11,"template":"","categories":[39],"tags":[],"class_list":["post-1537","press_release","type-press_release","status-publish","hentry","category-notas-de-prensa","entry"],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v22.5 - https:\/\/yoast.com\/wordpress\/plugins\/seo\/ -->\n<title>Juan Lobera, nuevo director m\u00e9dico y de asuntos regulatorios de Ipsen para Espa\u00f1a y Portugal - Spain<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.ipsen.com\/spain\/press-releases\/juan-lobera-nuevo-director-medico-y-de-asuntos-regulatorios-de-ipsen-para-espana-y-portugal\/\" \/>\n<meta property=\"og:locale\" content=\"es_ES\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Juan Lobera, nuevo director m\u00e9dico y de asuntos regulatorios de Ipsen para Espa\u00f1a y Portugal - Spain\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.ipsen.com\/spain\/press-releases\/juan-lobera-nuevo-director-medico-y-de-asuntos-regulatorios-de-ipsen-para-espana-y-portugal\/\" \/>\n<meta property=\"og:site_name\" content=\"Spain\" \/>\n<meta property=\"article:modified_time\" content=\"2024-12-16T11:25:32+00:00\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Tiempo de lectura\" \/>\n\t<meta name=\"twitter:data1\" content=\"3 minutos\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\/\/www.ipsen.com\/spain\/press-releases\/juan-lobera-nuevo-director-medico-y-de-asuntos-regulatorios-de-ipsen-para-espana-y-portugal\/\",\"url\":\"https:\/\/www.ipsen.com\/spain\/press-releases\/juan-lobera-nuevo-director-medico-y-de-asuntos-regulatorios-de-ipsen-para-espana-y-portugal\/\",\"name\":\"Juan Lobera, nuevo director m\u00e9dico y de asuntos regulatorios de Ipsen para Espa\u00f1a y Portugal - Spain\",\"isPartOf\":{\"@id\":\"https:\/\/www.ipsen.com\/spain\/#website\"},\"datePublished\":\"2020-09-01T11:27:45+00:00\",\"dateModified\":\"2024-12-16T11:25:32+00:00\",\"breadcrumb\":{\"@id\":\"https:\/\/www.ipsen.com\/spain\/press-releases\/juan-lobera-nuevo-director-medico-y-de-asuntos-regulatorios-de-ipsen-para-espana-y-portugal\/#breadcrumb\"},\"inLanguage\":\"es\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/www.ipsen.com\/spain\/press-releases\/juan-lobera-nuevo-director-medico-y-de-asuntos-regulatorios-de-ipsen-para-espana-y-portugal\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/www.ipsen.com\/spain\/press-releases\/juan-lobera-nuevo-director-medico-y-de-asuntos-regulatorios-de-ipsen-para-espana-y-portugal\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/www.ipsen.com\/spain\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Juan Lobera, nuevo director m\u00e9dico y de asuntos regulatorios de Ipsen para Espa\u00f1a y Portugal\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/www.ipsen.com\/spain\/#website\",\"url\":\"https:\/\/www.ipsen.com\/spain\/\",\"name\":\"Spain\",\"description\":\"\",\"publisher\":{\"@id\":\"https:\/\/www.ipsen.com\/spain\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/www.ipsen.com\/spain\/?s={search_term_string}\"},\"query-input\":\"required name=search_term_string\"}],\"inLanguage\":\"es\"},{\"@type\":\"Organization\",\"@id\":\"https:\/\/www.ipsen.com\/spain\/#organization\",\"name\":\"Spain\",\"url\":\"https:\/\/www.ipsen.com\/spain\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"es\",\"@id\":\"https:\/\/www.ipsen.com\/spain\/#\/schema\/logo\/image\/\",\"url\":\"https:\/\/www.ipsen.com\/websites\/ipsen_com_v2\/wp-content\/uploads\/sites\/17\/2024\/06\/25091900\/Logo-Ipsen-new.svg\",\"contentUrl\":\"https:\/\/www.ipsen.com\/websites\/ipsen_com_v2\/wp-content\/uploads\/sites\/17\/2024\/06\/25091900\/Logo-Ipsen-new.svg\",\"caption\":\"Spain\"},\"image\":{\"@id\":\"https:\/\/www.ipsen.com\/spain\/#\/schema\/logo\/image\/\"}}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Juan Lobera, nuevo director m\u00e9dico y de asuntos regulatorios de Ipsen para Espa\u00f1a y Portugal - Spain","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.ipsen.com\/spain\/press-releases\/juan-lobera-nuevo-director-medico-y-de-asuntos-regulatorios-de-ipsen-para-espana-y-portugal\/","og_locale":"es_ES","og_type":"article","og_title":"Juan Lobera, nuevo director m\u00e9dico y de asuntos regulatorios de Ipsen para Espa\u00f1a y Portugal - Spain","og_url":"https:\/\/www.ipsen.com\/spain\/press-releases\/juan-lobera-nuevo-director-medico-y-de-asuntos-regulatorios-de-ipsen-para-espana-y-portugal\/","og_site_name":"Spain","article_modified_time":"2024-12-16T11:25:32+00:00","twitter_card":"summary_large_image","twitter_misc":{"Tiempo de lectura":"3 minutos"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/www.ipsen.com\/spain\/press-releases\/juan-lobera-nuevo-director-medico-y-de-asuntos-regulatorios-de-ipsen-para-espana-y-portugal\/","url":"https:\/\/www.ipsen.com\/spain\/press-releases\/juan-lobera-nuevo-director-medico-y-de-asuntos-regulatorios-de-ipsen-para-espana-y-portugal\/","name":"Juan Lobera, nuevo director m\u00e9dico y de asuntos regulatorios de Ipsen para Espa\u00f1a y Portugal - Spain","isPartOf":{"@id":"https:\/\/www.ipsen.com\/spain\/#website"},"datePublished":"2020-09-01T11:27:45+00:00","dateModified":"2024-12-16T11:25:32+00:00","breadcrumb":{"@id":"https:\/\/www.ipsen.com\/spain\/press-releases\/juan-lobera-nuevo-director-medico-y-de-asuntos-regulatorios-de-ipsen-para-espana-y-portugal\/#breadcrumb"},"inLanguage":"es","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.ipsen.com\/spain\/press-releases\/juan-lobera-nuevo-director-medico-y-de-asuntos-regulatorios-de-ipsen-para-espana-y-portugal\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/www.ipsen.com\/spain\/press-releases\/juan-lobera-nuevo-director-medico-y-de-asuntos-regulatorios-de-ipsen-para-espana-y-portugal\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.ipsen.com\/spain\/"},{"@type":"ListItem","position":2,"name":"Juan Lobera, nuevo director m\u00e9dico y de asuntos regulatorios de Ipsen para Espa\u00f1a y Portugal"}]},{"@type":"WebSite","@id":"https:\/\/www.ipsen.com\/spain\/#website","url":"https:\/\/www.ipsen.com\/spain\/","name":"Spain","description":"","publisher":{"@id":"https:\/\/www.ipsen.com\/spain\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.ipsen.com\/spain\/?s={search_term_string}"},"query-input":"required name=search_term_string"}],"inLanguage":"es"},{"@type":"Organization","@id":"https:\/\/www.ipsen.com\/spain\/#organization","name":"Spain","url":"https:\/\/www.ipsen.com\/spain\/","logo":{"@type":"ImageObject","inLanguage":"es","@id":"https:\/\/www.ipsen.com\/spain\/#\/schema\/logo\/image\/","url":"https:\/\/www.ipsen.com\/websites\/ipsen_com_v2\/wp-content\/uploads\/sites\/17\/2024\/06\/25091900\/Logo-Ipsen-new.svg","contentUrl":"https:\/\/www.ipsen.com\/websites\/ipsen_com_v2\/wp-content\/uploads\/sites\/17\/2024\/06\/25091900\/Logo-Ipsen-new.svg","caption":"Spain"},"image":{"@id":"https:\/\/www.ipsen.com\/spain\/#\/schema\/logo\/image\/"}}]}},"_links":{"self":[{"href":"https:\/\/www.ipsen.com\/spain\/wp-json\/wp\/v2\/press_release\/1537","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.ipsen.com\/spain\/wp-json\/wp\/v2\/press_release"}],"about":[{"href":"https:\/\/www.ipsen.com\/spain\/wp-json\/wp\/v2\/types\/press_release"}],"author":[{"embeddable":true,"href":"https:\/\/www.ipsen.com\/spain\/wp-json\/wp\/v2\/users\/11"}],"version-history":[{"count":3,"href":"https:\/\/www.ipsen.com\/spain\/wp-json\/wp\/v2\/press_release\/1537\/revisions"}],"predecessor-version":[{"id":3054,"href":"https:\/\/www.ipsen.com\/spain\/wp-json\/wp\/v2\/press_release\/1537\/revisions\/3054"}],"wp:attachment":[{"href":"https:\/\/www.ipsen.com\/spain\/wp-json\/wp\/v2\/media?parent=1537"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.ipsen.com\/spain\/wp-json\/wp\/v2\/categories?post=1537"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.ipsen.com\/spain\/wp-json\/wp\/v2\/tags?post=1537"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}